Literature DB >> 11150641

Activation of urocortin transport into brain by leptin.

A J Kastin1, V Akerstrom, W Pan.   

Abstract

There are several transport systems for peptides and polypeptides at the blood-brain barrier (BBB) which facilitate the passage of bioactive substances from blood to brain or from brain to blood. Nonetheless, it would be a novel concept for one peptide or polypeptide to activate the transport of another peptide with a similar function but unrelated structure. In this study, we report the first observation of such a phenomenon: activation of a urocortin transport system at the BBB by leptin. Urocortin, a corticotropin-releasing factor (CRF)-related neuropeptide, is a more potent suppressor of food intake than leptin or CRF when injected peripherally. Radiolabeled urocortin ((125)I-urocortin) was used for these in vivo studies in mice; it remained stable and intact during the experimental period. Unlike CRF, urocortin was not saturably transported out of the brain. There was no substantial entry of (125)I-urocortin into brain as determined by sensitive multiple-time regression analysis after iv bolus injection. Addition of leptin, however, caused a dose-related increase in the influx of (125)I-urocortin and greatly facilitated its entry into brain parenchyma; this effect disappeared at higher doses of leptin. Moreover, in the presence of an activating dose of leptin, the entry of (125)I-urocortin into brain was saturable. The results indicate that the presence of leptin contributes to the potent satiety effects of urocortin after peripheral administration. Thus, the action of leptin in the periphery extends beyond its direct passage across the BBB and involves acute modulation of an inert transport system. We believe that these findings have broad physiological implications and indicate a unique function of the BBB as a regulatory interface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150641     DOI: 10.1016/s0196-9781(00)00349-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  17 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; N Joan Abbott; Pierre-Olivier Couraud; Weihong Pan
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 4.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

Review 5.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 6.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

7.  Gut-brain communications: not the same at all ages.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2010-03       Impact factor: 4.736

8.  Urocortin trafficking in cerebral microvessel endothelial cells.

Authors:  Hong Tu; Abba J Kastin; Christian Bjorbaek; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Unexpected amplification of leptin-induced Stat3 signaling by urocortin: implications for obesity.

Authors:  Weihong Pan; Hong Tu; Hung Hsuchou; Jeremy Daniel; Abba J Kastin
Journal:  J Mol Neurosci       Date:  2007-09-05       Impact factor: 3.444

Review 10.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.